Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Testosterone Deficiency: early-phase trial registry

1 of 2 indexed Testosterone Deficiency trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Testosterone Deficiency: 2 US clinical trials tracked, 1 recruiting.

Testosterone Deficiency is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Craig Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition testosterone-deficiency

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Testosterone Deficiency (thi…50%
Open-enrollment share among volume-matched conditions near Testosterone Deficiency

Testosterone Deficiency lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Testosterone Deficiency on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Testosterone Deficiency is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Testosterone Deficiency records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Testosterone gel Drug
1 trials
Blood Sampling Diagnostic test
1 trials
Intra-arterial Vitamin C Infusion Diagnostic test
1 trials
Intra-arterial Infusion of Vasoactive Agents Diagnostic test
1 trials

US sites by state

Facility locations filed on Testosterone Deficiency trials. A trial with sites in several states counts in each.

Missouri 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Testosterone Deficiency page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Testosterone Deficiency trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Craig Hospital sponsors the most Testosterone Deficiency trials on record, review their full trial history before evaluating a specific study. See Craig Hospital's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Testosterone Deficiency condition card totals 2 registered trials; most-linked intervention Testosterone gel; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.